Revofer^TM

Indication:
For the treatment of IDA in-
• Adult & pediatric patients of 1 year of age and older who have either intolerance or an unsatisfactory response to oral Iron
• Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)
• Heart failure patients to improve exercise capacity

Dosage & Administration:
For patients weighing 50 kg or more, the recommended dosage is:
• 750 mg intravenously in two doses separated by at least 7 days for a total cumulative dose of 1,500 mg of Iron per course
• 15 mg/kg body weight up to a maximum of 1,000 mg intravenously as a single dose per course
For patients weighing less than 50 kg, the recommended dosage is:
• 15 mg/kg body weight intravenously in two doses separated by at least 7 days per course
Method of Administration:
Revofer^TM must be administered only by the intravenous route: by bolus injection or by infusion. It must be diluted only in sterile 0.9% Sodium Chloride solution as shown in the below table:
Dilution plan of Revofer^TM for Intravenous Infusion:

Preparation:
Revofer^TM 500 IV Injection: Each box contains one vial of 10 ml Ferric Carboxymaltose solution with one 100 ml 0.9% Sodium Chloride solution, Infusion Set, First Aid Band, Alcohol Pad & 10 ml sterile Disposable Syringe.
Revofer^TM 750 IV Injection: Each box contains one vial of 15 ml Ferric Carboxymaltose solution with one 250 ml 0.9% Sodium Chloride solution, Infusion Set, First Aid Band, Alcohol Pad & 10 ml sterile Disposable Syringe.
Revofer^TM 1 gm IV Injection: Each box contains one vial of 20 ml Ferric Carboxymaltose solution with one 250 ml 0.9% Sodium Chloride solution, Infusion Set, First Aid Band, Alcohol Pad & 20 ml sterile Disposable Syringe.